Cancer-Fighting cell therapy tested for devastating lupus kidney damage
Disease control
Not yet recruiting
This early-stage study is testing a new personalized cell therapy called CRC01 for people with severe lupus nephritis, a serious kidney complication of lupus. The therapy involves modifying a patient's own immune cells (CAR-T cells) to target and potentially reset the faulty immu…
Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC